Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Diabetes is Scopus-indexed (Q1, CiteScore 7.1), WoS SCIE, DOAJ. Published by Wiley-Blackwell.
Checked against the index lists dated .
ISSN 1753-0393Verify ISSN ↗1753-0407Verify ISSN ↗
Publisher: Wiley-Blackwell
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Endocrinology, Diabetes and Metabolism | 62 / 250 | 75th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2009–present, best quartile Q1, CiteScore 7.1.
Journal of Diabetes is Q1 in Endocrinology, Diabetes and Metabolism (rank 62 of 250), by CiteScore 2025.
Journal of Diabetes is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7.1, which places it in quartile Q1 at the 75th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.439, quartile Q1, with an H-index of 67.
The publisher lists an article processing charge of about US$3,000 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Journal of Diabetes is published by Wiley-Blackwell. Its print ISSN is 1753-0393 and its online ISSN is 1753-0407.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Journal of Diabetes has an h-index of 75 and a 2-year mean of 4.63 citations per paper (OpenAlex). Its Scopus CiteScore is 7.1, quartile Q1. On 2-year citations it ranks #41 of 246 Scopus journals in Endocrinology, Diabetes and Metabolism.
Journal of Diabetes published 163 papers in 2025; its busiest recent year was 2023 with 183. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2025–2026), authors are most often from China (51.8%), United States (18.4%) and South Korea (4.1%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 5 retracted papers are recorded (2.3 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.